Liangxing Wu,Leah C. Konkol,Neil Lajkiewicz,Liang Lu,Meizhong Xu,Wenqing Yao,Zhiyong Yu,Colin Zhang,Chunhong He
申请号：
US14795536
公开号：
US09695168B2
申请日:
2015.07.09
申请国别(地区):
US
年份:
2017
代理人:
摘要：
The present invention is directed to imidazo[1,5-a]pyridine and imidazo[1,5-a]pyrazine derivatives of Formula I, or a pharmaceutically acceptable salt thereof, which are LSD1 inhibitors useful in the treatment of diseases such as cancer.
